Rare Diseases: Drugs
Commons · Question 83989 · Tabled 21 Oct 2025 · Department of Health and Social Care · Official record
Answered 6 Nov 2025
Question
Asked by John Milne
To ask the Secretary of State for Health and Social Care, how many of the commercial arrangements made by NHS England with marketing authorisation holders between January 2020 and September 2025 involving indication-specific pricing were for indications f
Answer
Answered by Zubir Ahmed, 6 Nov 2025
Between January 2020 and September 2025, NHS England entered into 75 commercial arrangements involving indication-specific pricing. Of these, eight of the commercial agreements have involved indication-specific pricing for rare non-oncology conditions, an...